Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells

Cheng Jeng Tai, Jin Wun Wang, Hou Yu Su, Chen Jei Tai, Chien Kai Wang, Chun Te Wu, Yung Chang Lien, Yu Jia Chang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Cervical cancer is an important health issue for women worldwide, and the endoplasmic reticulum stress pathway is important for determining the chemotherapeutic response to cancer. However, the role of glucose-regulated protein 94 (GRP94) in taxane therapy for cervical cancer remains unclear. In this study, we generated GRP94 knockdown (GRP94-KD) Hela cells using short hairpin RNAs and found that GRP94-KD cells were resistant to taxane treatment in an MTT assay. Scrambled control cells demonstrated higher levels of apoptosis when treated with taxanes in comparison to GRP94-KD cells, as determined by cell cycle profiling, 4′,6-diamidino-2-phenylindole staining, and terminal deoxynucleotidyl transferase-mediated nick end labeling staining. Caspase 3 and caspase 7 activity was also higher in scrambled control cells treated with taxane in comparison to GRP94-KD cells. Moreover, we found that depletion of GRP94 altered the levels of the apoptosis-related proteins Bcl2 and Bad, leading to sensitivity to taxane. Exposure to taxane also induced the expression of Bad in scrambled cells but not in GRP94-KD cells. In addition, the expression of Bcl2 was increased dramatically in GRP94-KD cells, whereas only a small increase was observed in scrambled cells. Therefore, we conclude that silencing GRP94 may increase resistance to taxane treatment in cervical cancer cells by altering the activation of the apoptosis pathway. In addition, GRP94 may represent a key biomarker for determining the therapeutic efficacy of taxane treatment in cervical cancer patients.

Original languageEnglish
Pages (from-to)403-410
Number of pages8
JournalTumor Biology
Volume35
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Uterine Cervical Neoplasms
Therapeutics
Apoptosis
bcl-Associated Death Protein
glucose-regulated proteins
taxane
Staining and Labeling
Caspase 7
Taxoids
Endoplasmic Reticulum Stress
DNA Nucleotidylexotransferase
Women's Health
HeLa Cells
Caspase 3
Small Interfering RNA
Cell Cycle
Biomarkers

Keywords

  • Cervical cancer
  • Chemoresistant
  • GRP94
  • Taxane

ASJC Scopus subject areas

  • Cancer Research

Cite this

Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells. / Tai, Cheng Jeng; Wang, Jin Wun; Su, Hou Yu; Tai, Chen Jei; Wang, Chien Kai; Wu, Chun Te; Lien, Yung Chang; Chang, Yu Jia.

In: Tumor Biology, Vol. 35, No. 1, 01.2014, p. 403-410.

Research output: Contribution to journalArticle

Tai, Cheng Jeng ; Wang, Jin Wun ; Su, Hou Yu ; Tai, Chen Jei ; Wang, Chien Kai ; Wu, Chun Te ; Lien, Yung Chang ; Chang, Yu Jia. / Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells. In: Tumor Biology. 2014 ; Vol. 35, No. 1. pp. 403-410.
@article{cbb987a8b21e4064ba36184a60965e13,
title = "Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells",
abstract = "Cervical cancer is an important health issue for women worldwide, and the endoplasmic reticulum stress pathway is important for determining the chemotherapeutic response to cancer. However, the role of glucose-regulated protein 94 (GRP94) in taxane therapy for cervical cancer remains unclear. In this study, we generated GRP94 knockdown (GRP94-KD) Hela cells using short hairpin RNAs and found that GRP94-KD cells were resistant to taxane treatment in an MTT assay. Scrambled control cells demonstrated higher levels of apoptosis when treated with taxanes in comparison to GRP94-KD cells, as determined by cell cycle profiling, 4′,6-diamidino-2-phenylindole staining, and terminal deoxynucleotidyl transferase-mediated nick end labeling staining. Caspase 3 and caspase 7 activity was also higher in scrambled control cells treated with taxane in comparison to GRP94-KD cells. Moreover, we found that depletion of GRP94 altered the levels of the apoptosis-related proteins Bcl2 and Bad, leading to sensitivity to taxane. Exposure to taxane also induced the expression of Bad in scrambled cells but not in GRP94-KD cells. In addition, the expression of Bcl2 was increased dramatically in GRP94-KD cells, whereas only a small increase was observed in scrambled cells. Therefore, we conclude that silencing GRP94 may increase resistance to taxane treatment in cervical cancer cells by altering the activation of the apoptosis pathway. In addition, GRP94 may represent a key biomarker for determining the therapeutic efficacy of taxane treatment in cervical cancer patients.",
keywords = "Cervical cancer, Chemoresistant, GRP94, Taxane",
author = "Tai, {Cheng Jeng} and Wang, {Jin Wun} and Su, {Hou Yu} and Tai, {Chen Jei} and Wang, {Chien Kai} and Wu, {Chun Te} and Lien, {Yung Chang} and Chang, {Yu Jia}",
year = "2014",
month = "1",
doi = "10.1007/s13277-013-1056-9",
language = "English",
volume = "35",
pages = "403--410",
journal = "Tumor Biology",
issn = "1010-4283",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells

AU - Tai, Cheng Jeng

AU - Wang, Jin Wun

AU - Su, Hou Yu

AU - Tai, Chen Jei

AU - Wang, Chien Kai

AU - Wu, Chun Te

AU - Lien, Yung Chang

AU - Chang, Yu Jia

PY - 2014/1

Y1 - 2014/1

N2 - Cervical cancer is an important health issue for women worldwide, and the endoplasmic reticulum stress pathway is important for determining the chemotherapeutic response to cancer. However, the role of glucose-regulated protein 94 (GRP94) in taxane therapy for cervical cancer remains unclear. In this study, we generated GRP94 knockdown (GRP94-KD) Hela cells using short hairpin RNAs and found that GRP94-KD cells were resistant to taxane treatment in an MTT assay. Scrambled control cells demonstrated higher levels of apoptosis when treated with taxanes in comparison to GRP94-KD cells, as determined by cell cycle profiling, 4′,6-diamidino-2-phenylindole staining, and terminal deoxynucleotidyl transferase-mediated nick end labeling staining. Caspase 3 and caspase 7 activity was also higher in scrambled control cells treated with taxane in comparison to GRP94-KD cells. Moreover, we found that depletion of GRP94 altered the levels of the apoptosis-related proteins Bcl2 and Bad, leading to sensitivity to taxane. Exposure to taxane also induced the expression of Bad in scrambled cells but not in GRP94-KD cells. In addition, the expression of Bcl2 was increased dramatically in GRP94-KD cells, whereas only a small increase was observed in scrambled cells. Therefore, we conclude that silencing GRP94 may increase resistance to taxane treatment in cervical cancer cells by altering the activation of the apoptosis pathway. In addition, GRP94 may represent a key biomarker for determining the therapeutic efficacy of taxane treatment in cervical cancer patients.

AB - Cervical cancer is an important health issue for women worldwide, and the endoplasmic reticulum stress pathway is important for determining the chemotherapeutic response to cancer. However, the role of glucose-regulated protein 94 (GRP94) in taxane therapy for cervical cancer remains unclear. In this study, we generated GRP94 knockdown (GRP94-KD) Hela cells using short hairpin RNAs and found that GRP94-KD cells were resistant to taxane treatment in an MTT assay. Scrambled control cells demonstrated higher levels of apoptosis when treated with taxanes in comparison to GRP94-KD cells, as determined by cell cycle profiling, 4′,6-diamidino-2-phenylindole staining, and terminal deoxynucleotidyl transferase-mediated nick end labeling staining. Caspase 3 and caspase 7 activity was also higher in scrambled control cells treated with taxane in comparison to GRP94-KD cells. Moreover, we found that depletion of GRP94 altered the levels of the apoptosis-related proteins Bcl2 and Bad, leading to sensitivity to taxane. Exposure to taxane also induced the expression of Bad in scrambled cells but not in GRP94-KD cells. In addition, the expression of Bcl2 was increased dramatically in GRP94-KD cells, whereas only a small increase was observed in scrambled cells. Therefore, we conclude that silencing GRP94 may increase resistance to taxane treatment in cervical cancer cells by altering the activation of the apoptosis pathway. In addition, GRP94 may represent a key biomarker for determining the therapeutic efficacy of taxane treatment in cervical cancer patients.

KW - Cervical cancer

KW - Chemoresistant

KW - GRP94

KW - Taxane

UR - http://www.scopus.com/inward/record.url?scp=84894418783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894418783&partnerID=8YFLogxK

U2 - 10.1007/s13277-013-1056-9

DO - 10.1007/s13277-013-1056-9

M3 - Article

C2 - 23929391

AN - SCOPUS:84894418783

VL - 35

SP - 403

EP - 410

JO - Tumor Biology

JF - Tumor Biology

SN - 1010-4283

IS - 1

ER -